Article Information
History
- February 8, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Marco Massari1,*,
- Stefania Spila-Alegiani1,*,
- Cristina Morciano1,§,
- Matteo Spuri2,
- Pasquale Marchione3,
- Patrizia Felicetti3,
- Valeria Belleudi4,
- Francesca Romana Poggi4,
- Marco Lazzeretti5,
- Michele Ercolanoni5,
- Elena Clagnan6,
- Emanuela Bovo7,
- Gianluca Trifirò8,
- Ugo Moretti8,
- Giuseppe Monaco9,
- Olivia Leone9,
- Roberto Da Cas1,
- Fiorella Petronzelli3,
- Loriana Tartaglia3,
- Nadia Mores10,
- Giovanna Zanoni11,
- Paola Rossi12,
- Sarah Samez13,
- Cristina Zappetti12,
- Anna Rosa Marra3,
- Francesca Menniti-Ippolito1 and
- the TheShinISS-vax|COVID Surveillance Group14
- 1National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy
- 2Department of Infectious Diseases, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy
- 3Department of post-marketing surveillance, Agenzia Italiana del Farmaco (Italian Medicines Agency), Rome, Italy
- 4Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy
- 5Business Intelligence, Data Science e Data Analysis, ARIA S.p.A., Milan, Italy
- 6ARCS – Azienda Regionale di Coordinamento per la Salute, Udine, Italy
- 7Veneto Tumour Registry, Azienda Zero, Padova, Italy
- 8Department of Diagnostics and Public Health, University of Verona, Verona, Italy
- 9Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy
- 10Institute of Pharmacology, Pharmacovigilance, Policlinico Universitario A. Gemelli, Catholic University of Sacred Heart, Rome, Italy
- 11Immunology Unit, University Hospital, Verona, Italy
- 12Direzione centrale salute, politiche sociali e disabilità, Friuli Venezia Giulia Region, Trieste, Italy
- 13Centro Regionale di Farmacovigilanza, Friuli Venezia Giulia Region, Trieste, Italy
- ↵§Corresponding author Correspondence to: Cristina Morciano, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità (National Institute of Health), Rome, Italy, cristina.morciano{at}iss.it
↵* contributed equally as first authors